The mechanism underlying DMF's beneficial effect in multiple sclerosis and psoriasis is unclear and is commonly suggested to be mediated via NRF2 activation, although NRF2‐independent effects are also reported [63]. Here, NFE2L2 is linked to multiple sclerosis.